Background pattern

Jinarc 15 mg + 45 mg comprimidos

About the medicine

How to use Jinarc 15 mg + 45 mg comprimidos

Introduction

Prospect: information for the patient

Jinarc 15 mg tablets

Jinarc 30 mg tablets

Jinarc 45 mg tablets

Jinarc 60 mg tablets

Jinarc 90 mg tablets

Tolvaptan

This medicine is subject to additional monitoring, which will speed up the detection of new information about its safety. You can contribute by reporting any adverse effects you may experience. The final part of section 4 includes information on how to report these adverse effects.

Read this prospect carefully before starting to take this medicine, because

it contains important information for you.

  • Keep this prospect, as you may need to read it again.
  • If you have any doubts, consult your doctor or pharmacist.
  • This medicine has been prescribed only for you, and you must not give it to other people
  • who may have the same symptoms as you, as it may harm them.
  • If you experience adverse effects, consult your doctor or pharmacist even if they are
  • adverse effects that do not appear in this prospect. See section 4.

1. What is Jinarc and how is it used

Jinarc is a medication used to treat a disease known as «autosomal dominant polycystic kidney disease» (ADPKD). This disease leads to the development of fluid-filled cysts in the kidneys, causing pressure on surrounding tissues and reducing kidney function, potentially leading to kidney failure. Jinarc is used to treat ADPKD in adults with chronic kidney disease (CKD) in stages 1 to 4 with signs of rapid disease progression.

The active ingredient of Jinarc is tolvaptan, which blocks the effect of vasopressin, a hormone involved in the formation of cysts in the kidneys of patients with ADPKD. By blocking the effect of vasopressin, Jinarc slows the development of kidney cysts in patients with ADPKD, reduces disease symptoms, and increases urine production.

2. What you need to know before starting Jinarc

Do not take Jinarc:

  • If you are allergic to tolvaptan or any of the other ingredients of this medicine (listed in section 6) or if you are allergic to benzazepine or benzazepine derivatives (for example, benazepril, conivaptan, mesilato de fenoldopam or mirtazapina).
  • If you have been told that you have high levels of liver enzymes in your blood and this prevents you from receiving treatment with tolvaptan.
  • If your kidneys do not function (no urine production)
  • If you have a condition associated with very low blood volume (e.g., severe dehydration or hemorrhage).
    • If you have a condition that increases the amount of sodium in your blood.
    • If you do not feel the sensation of thirst.
    • If you are pregnant (see "Pregnancy and breastfeeding").
    • If you are breastfeeding (see "Pregnancy and breastfeeding").

Warnings and precautions

Consult your doctor before starting to take Jinarc:

  • If you have liver disease.
  • If you cannot drink enough water (see "Drink a sufficient amount of water" below) or if you have to limit your liquid intake.
    • If you have difficulty urinating or prostatic hypertrophy (enlargement of the prostate).
    • If you have a blood sodium level that is too high or too low.
  • If you have had a past allergic reaction to benzazepine, tolvaptan or other benzazepine derivatives (e.g., benazepril, conivaptan, mesilato de fenoldopam or mirtazapina), or to any of the other ingredients of this medicine (listed in section 6).
    • If you have diabetes.
    • If you have been told that you have high levels of uric acid in your blood (which may have caused gout).
  • Inform your doctor immediately if you experience signs that may indicate liver problems, such as:
  • Nausea
  • Vomiting
  • Fever
  • Fatigue
  • Loss of appetite
  • Abdominal pain
  • Dark urine
  • Icterus (yellowing of the skin or eyes)
  • Pruritus (itching) of the skin
  • Symptoms of pseudogripal syndrome (muscle and joint pain with fever)

During treatment with Jinarc, your doctor will request monthly blood tests to monitor any changes in your liver function.

Drink a sufficient amount of water

Jinarc causes water loss because it increases urine production. This water loss may lead to side effects such as dry mouth and thirst, or even more serious side effects such as kidney problems (see section 4). Therefore, it is essential that you have access to water and can ingest sufficient amounts of liquid when you feel thirsty. Before going to bed, you should drink one or two glasses of water even if you do not feel thirsty, and also drink water after urinating at night. You should be particularly careful if you have a disease that reduces your ability to ingest adequate amounts of liquid or if you have a higher risk of dehydration, for example if you have vomiting or diarrhea. Due to the increased urine production, it is also essential to have a bathroom nearby at all times.

Children and adolescents

Jinarc has not been studied in children and adolescents (under 18 years) and is therefore not recommended for use in this population.

Other medicines and Jinarc

Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine, even over-the-counter medicines.

In particular, inform your doctor that you are taking:

  • Treatments containing ketoconazole for fungal infections, macrolide antibiotics such as clarithromycin, or diltiazem for hypertension and chest pain.
  • These medicines may increase the effects of Jinarc.
  • Medicines that increase the level of sodium in the blood or that contain large amounts of salt, such as tablets that dissolve in water and those used to treat indigestion. These may increase the effects of Jinarc.
  • Digoxin (a medicine for treating irregular heart rhythm and heart failure), dabigatran (used as an anticoagulant), rosuvastatin or pitavastatin (used to reduce blood cholesterol levels), methotrexate (used to treat cancer and arthritis), ciprofloxacin (an antibiotic), sulfasalazine (for the treatment of irritable bowel disease or rheumatoid arthritis) or metformin (for the treatment of diabetes). Jinarc may increase the effect of these medicines.
  • Phenytoin or carbamazepine (medicines for treating epilepsy), rifampicin (a medicine for treating tuberculosis) or St. John's Wort (a traditional herbal remedy for mild depression and anxiety). It is advisable to avoid the use of any of these medicines in combination with Jinarc because they may reduce the effects of Jinarc.
  • Diuretics (used to increase urine production). When taken at the same time as Jinarc, these medicines may increase the risk of side effects due to water loss.
  • Diuretics or other medicines for treating hypertension. When taken at the same time as Jinarc, these medicines may increase the risk of experiencing low blood pressure when standing up or getting up.
  • Desmopressin (used to increase blood clotting factors or to control urine production or urinary incontinence). Jinarc may reduce the effect of desmopressin.

It may not be a problem to take these medicines at the same time as Jinarc. Your doctor will decide what is best for you.

Use of Jinarc with beverages and alcohol

Do not take grapefruit juice while taking Jinarc.

Pregnancy and breastfeeding

Do nottake this medicine if you are pregnant or breastfeeding.

Potentially fertile women should use reliable contraceptive methods while being treated with this medicine.

If you are pregnant or breastfeeding, or if you think you may be pregnant or are planning to become pregnant, consult your doctor or pharmacist before taking this medicine.

Driving and operating machinery

Some people may feel dizzy, weak, or tired after taking Jinarc. If you experience these effects, do not drive or use tools or machinery.

Jinarc contains lactose.

If your doctor has told you that you have a lactose intolerance, consult with him before taking this medicine.

3. How to Take Jinarc

Only specialized doctors in the treatment of PQRAD can prescribe Jinarc. Follow exactly the administration instructions of this medication indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.

Dosage

The daily dose of Jinarc should be divided into two doses, one higher than the other. The higher dose should be taken in the morning upon waking, at least 30 minutes before breakfast, while the lower dose should be taken 8 hours later.

The dose combinations are:

45 mg + 15 mg

60 mg + 30 mg

90 mg + 30 mg

Normally, your treatment will start with a dose of 45 mg in the morning and 15 mg 8 hours later. Your doctor may gradually increase your dose to a maximum combination of 90 mg upon waking and 30 mg 8 hours later. Your doctor will regularly check how you tolerate the prescribed dose to determine the best dose for you. Always take the highest tolerable dose combination prescribed by your doctor.

If you are taking other medications that may increase the effects of Jinarc, you may receive lower doses. In this case, your doctor may prescribe Jinarc tablets with 30 or 15 mg of tolvaptan, which you should take once a day in the morning.

Administration form

Swallow the tablets without chewing and accompanied by a glass of water.

The morning dose should be taken at least 30 minutes before breakfast. The second daily dose may be taken with or without food.

If you take more Jinarc than you should

If you have taken more tablets than the prescribed dose,drink plenty of water and immediately contact your doctor or the nearest hospital.Remember to carry the medication box with you so it is clear what you have taken. If you take the higher dose too late, you may need to go to the bathroom more frequently at night.

If you forget to take Jinarc

If you forget to take your medication, take the dose as soon as you remember on the same day. If you have not taken the tablets for a day, take the normal dose the next day.Do not take a double dose to compensate for the missed individual doses.

If you interrupt treatment with Jinarc

If you interrupt treatment with Jinarc, the kidney cysts may grow as quickly as before starting treatment with this medication. Therefore, you should only stop taking Jinarc if you notice emergency medical attention required side effects (see section 4) or if your doctor advises you to do so.

If you have any doubts about the use of this medication, consult your doctor or pharmacist.

4. Possible Adverse Effects

Like all medicines, this medicine can cause side effects, although not everyone will experience them.

Severe side effects:

If you experience any of the following side effects, you may need urgent medical attention. Stop taking Jinarc and contact a doctor immediately or go to the nearest hospital if:

  • You have difficulty urinating;
  • You experience swelling of the face, lips, or tongue, feel itchy, have a generalised skin rash, or have wheezing or difficulty breathing (symptoms of an allergic reaction).

Jinarc may cause your liver not to function properly.

Consult your doctor if you experience symptoms of nausea, vomiting, fever, fatigue, loss of appetite, abdominal pain, dark urine, jaundice (yellowing of the skin or eyes), skin itching, or joint and muscle pain with fever.

Other side effects:

Very common: may affect more than 1 in 10 people

  • Thirst (excessive need to drink water)
  • Headache
  • Dizziness
  • Diarrhea
  • Dry mouth
  • Increased need to urinate, urinate at night, or urinate more frequently
  • Fatigue

Common: may affect up to 1 in 10 people

  • Dehydration
  • Elevated sodium, uric acid, and blood sugar concentrations
  • Gout
  • Loss of appetite
  • Difficulty falling asleep
  • Palpitations
  • Difficulty breathing
  • Abdominal pain
  • Feeling full, having a bloated stomach, or experiencing stomach discomfort
  • Constipation
  • Heartburn
  • Abnormal liver function
  • Skin rash
  • Itching
  • Muscle spasms
  • General weakness
  • Elevated liver enzyme concentrations in the blood
  • Weight loss

Rare: may affect up to 1 in 100 people

  • Elevated bilirubin concentration (a substance that can cause yellowing of the skin or eyes) in the blood

Unknown frequency: cannot be estimated from available data

  • Allergic reactions (see above)
  • Acute liver failure (ALF)

Reporting of side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the national notification system included in theAppendix V. By reporting side effects, you can contribute to providing more information on the safety of this medicine.

5. Conservation of Jinarc

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the outer box, on the blister pack, and on the blister after the abbreviation «CAD». The expiration date is the last day of the month indicated.

Store in the original packaging to protect it from light and moisture.

Medicines should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the packaging and medications that you no longer need. This will help protect the environment.

6. Contents of the packaging and additional information

Composition of Jinarc

The active ingredient is tolvaptan.

Each Jinarc 15 mg tablet contains 15 mg of tolvaptan.

Each Jinarc 30 mg tablet contains 30 mg of tolvaptan.

Each Jinarc 45 mg tablet contains 45 mg of tolvaptan.

Each Jinarc 60 mg tablet contains 60 mg of tolvaptan.

Each Jinarc 90 mg tablet contains 90 mg of tolvaptan.

The other components are lactose monohydrate (see section 2), maize starch, microcrystalline cellulose, hydroxypropyl cellulose, magnesium stearate and aluminium lake of indigo carmine.

Appearance of Jinarc and contents of the pack

The different doses of Jinarc tablets have different shapes and markings:

Jinarc 15 mg tablet: blue, triangular, marked with "OTSUKA" and "15" on one side.

Jinarc 30 mg tablet: blue, round, marked with "OTSUKA" and "30" on one side.

Jinarc 45 mg tablet: blue, square, marked with "OTSUKA" and "45" on one side.

Jinarc 60 mg tablet: blue, modified rectangular, marked with "OTSUKA" and "60" on one side.

Jinarc 90 mg tablet: blue, pentagonal, marked with "OTSUKA" and "90" on one side.

The medicinal product is supplied in the following pack sizes:

Jinarc 15 mg tablets: blisters with 7 or 28 tablets

Jinarc 30 mg tablets: blisters with 7 or 28 tablets

Jinarc 45 mg tablets + Jinarc 15 mg tablets: blisters with or without a carton with

14 (7 tablets of the higher dose + 7 tablets of the lower dose),

28 (14 tablets of the higher dose + 14 tablets of the lower dose) or

56 (28 tablets of the higher dose + 28 tablets of the lower dose) tablets.

Jinarc 60 mg tablets + Jinarc 30 mg tablets: blisters with or without a carton with 14 (7 tablets of the higher dose + 7 tablets of the lower dose),

28 (14 tablets of the higher dose + 14 tablets of the lower dose) or

56 (28 tablets of the higher dose + 28 tablets of the lower dose) tablets.

Jinarc 90 mg tablets + Jinarc 30 mg tablets: blisters with or without a carton with

14 (7 tablets of the higher dose + 7 tablets of the lower dose),

28 (14 tablets of the higher dose + 14 tablets of the lower dose) or

56 (28 tablets of the higher dose + 28 tablets of the lower dose) tablets.

Only some pack sizes may be marketed.

Marketing authorisation holder

Otsuka Pharmaceutical Netherlands B.V.

Herikerbergweg 292

1101 CT, Amsterdam

Netherlands

Manufacturer

AndersonBrecon (UK) Limited

Units 2-7, Wye Valley Business Park, Brecon Road, Hay-on-Wye

Hereford - HR3 5PG

UK

Almac Pharma Services Ltd.

Almac House, 20 Seagoe Industrial Estate

Craigavon - BT63 5QD

UK

Almac Pharma Service (Ireland) Limited

Finnabair Industrial Estate, Dundalk,

Co. Louth - A91 P9KD

Ireland

Millmount Healthcare Limited

Block-7, City North Business Campus, Stamullen, Co.

Meath, K32 YD60

Ireland

For further information about this medicinal product, please contact the local representative of the marketing authorisation holder:

België/Belgique/Belgien

Otsuka Pharmaceutical Netherlands B.V.

Tel: +31 (0) 20 85 46 555

Lietuva

Otsuka Pharmaceutical Netherlands B.V.

Tel: +31 (0) 20 85 46 555

????

Otsuka Pharmaceutical Netherlands B.V.

Te?: +31 (0) 20 85 46 555

Luxembourg/Luxemburg

Otsuka Pharmaceutical Netherlands B.V.

Tel: +31 (0) 20 85 46 555

Ceská republika

Otsuka Pharmaceutical Netherlands B.V.

Tel: +31 (0) 20 85 46 555

Magyarország

Otsuka Pharmaceutical Netherlands B.V.

Tel: +31 (0) 20 85 46 555

Danmark

Otsuka Pharma Scandinavia AB

Tlf: +46854 528 660

Malta

Otsuka Pharmaceutical Netherlands B.V.

Tel: +31 (0) 20 85 46 555

Deutschland

Otsuka Pharma GmbH

Tel: +49691 700 860

Nederland

Otsuka Pharmaceutical Netherlands B.V.

Tel: +31 (0) 20 85 46 555

Eesti

Otsuka Pharmaceutical Netherlands B.V.

Tel: +31 (0) 20 85 46 555

Norge

Otsuka Pharma Scandinavia AB

Tlf: +46854 528 660

Ελλάδα

Otsuka Pharmaceutical Netherlands B.V.

Thλ: +31 (0) 20 85 46 555

Österreich

Otsuka Pharmaceutical Netherlands B.V.

Tel: +31 (0) 20 85 46 555

España

Otsuka Pharmaceutical S.A

Tel: +3493 2081 020

Polska

Otsuka Pharmaceutical Netherlands B.V.

Tel: +31 (0) 20 85 46 555

France

Otsuka Pharmaceutical France SAS

Tél: +33147 080 000

Portugal

Otsuka Pharmaceutical Netherlands B.V.

Tel: +31 (0) 20 85 46 555

Hrvatska

Otsuka Pharmaceutical Netherlands B.V.

Tel: +31 (0) 20 85 46 555

România

Otsuka Pharmaceutical Netherlands B.V.

Tel: +31 (0) 20 85 46 555

Ireland

Otsuka Pharmaceutical Netherlands B.V.

Tel: +31 (0) 20 85 46 555

Slovenija

Otsuka Pharmaceutical Netherlands B.V.

Tel: +31 (0) 20 85 46 555

Ísland

Otsuka Pharma Scandinavia AB

Sími: +46854 528 660

Slovenská republika

Otsuka Pharmaceutical Netherlands B.V.

Tel: +31 (0) 20 85 46 555

Italia

Otsuka Pharmaceutical Italy S.r.l.

Tel: +39 02 00 63 27 10

Suomi/Finland

Otsuka Pharma Scandinavia AB

Puh/Tel: +46854 528 660

Κύπρος

Otsuka Pharmaceutical Netherlands B.V.

Thλ: +31 (0) 20 85 46 555

Sverige

Otsuka Pharma Scandinavia AB

Tel: +46854 528 660

Latvija

Otsuka Pharmaceutical Netherlands B.V.

Tel: +31 (0) 20 85 46 555

United Kingdom

Otsuka Pharmaceuticals (UK) Ltd.

Tel: +44 (0)203 747 5300

Date of last revision of this leaflet: MM/AAAA.

Other sources of information

Further detailed information on this medicinal product is available on the website of the European Medicines Agency:

http://www.ema.europa.eu/

Talk to a doctor online

Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.

5.07 reviews
Doctor

Anna Moret

Dermatology18 years of experience

Dr. Anna Moret is a board-certified dermatologist and dermatovenereologist. She specialises in adult and pediatric dermatology, venereology, aesthetic skin care, and general medicine. Her consultations are evidence-based and tailored to each patient’s dermatological needs.

Dr. Moret provides expert evaluation and treatment for: • Skin conditions such as eczema, acne, rosacea, dermatitis, and psoriasis • Hair and scalp issues including hair loss, dandruff, and seborrheic dermatitis • Pediatric skin problems — from newborns to adolescents • Sexually transmitted infections (STIs) and dermatovenereology • Aesthetic concerns: skin ageing, non-invasive cosmetic treatments • Skin allergies and hypersensitivity reactions • Mole checks, lesion evaluation, and skin cancer screening • Skincare advice and personalised cosmeceutical routines

Combining dermatology with general medical knowledge, Dr. Moret offers comprehensive care that addresses both skin health and underlying conditions. She also holds certification from the Canadian Board of Aesthetic Medicine, ensuring an internationally aligned approach to aesthetic dermatology.

CameraBook a video appointment
5.043 reviews
Doctor

Alina Tsurkan

Family medicine12 years of experience

Dr. Alina Tsurkan is a licensed family medicine physician based in Portugal, offering online consultations for adults and children. She provides professional primary care, with a focus on prevention, accurate diagnosis, and long-term management of acute and chronic conditions.

Dr. Tsurkan supports patients with a wide range of health issues, including: • Respiratory infections: cold, flu, bronchitis, pneumonia, and lingering coughs • ENT conditions: sinusitis, tonsillitis, otitis (ear infections), sore throat, allergic rhinitis • Eye conditions: allergic or infectious conjunctivitis, red eyes, irritation • Digestive issues: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), constipation, bloating, nausea • Urinary and reproductive health: urinary tract infections (UTIs), cystitis, prevention of recurrent infections • Chronic diseases: hypertension, diabetes, thyroid disorders, elevated cholesterol, weight management • Neurological complaints: headaches, migraines, sleep disturbances, fatigue, general weakness • Women’s health: menstrual irregularities, perimenopausal symptoms, preventive screening • Children’s health: fever, infections, digestive issues, follow-ups, vaccination guidance

She also provides: • IMT medical certificates for driving licence exchange in Portugal • Personalised preventive care and wellness consultations • Interpretation of test results and medical reports • Follow-up care and medication review • Support in managing multiple coexisting conditions • Remote prescription management and medical documentation

Dr. Tsurkan’s approach is evidence-based and holistic. She works closely with each patient to develop an individualised care plan that addresses both symptoms and root causes. Her goal is to empower patients to take control of their health and maintain well-being through lifestyle adjustments, routine check-ups, and early intervention.

CameraBook a video appointment
5.078 reviews
Doctor

Andrei Popov

General medicine6 years of experience

Dr. Andrei Popov is a licensed pain management specialist and general practitioner based in Spain. He provides expert online care for adults dealing with both chronic and acute pain, as well as a wide range of everyday health concerns.

He specialises in diagnosing and treating pain conditions that affect quality of life, including: • Chronic pain lasting more than 3 months • Migraines and recurring headaches • Neck, back, lower back, and joint pain • Post-traumatic pain following injury or surgery • Nerve-related pain, fibromyalgia, and neuralgia In addition to pain management, Dr. Popov helps patients with: • Respiratory infections (colds, bronchitis, pneumonia) • High blood pressure and metabolic conditions such as diabetes • Preventive care and routine health check-ups

Online consultations last up to 30 minutes and include a detailed symptom review, personalised treatment planning, and medical follow-up when needed.

Dr. Popov’s approach is rooted in evidence-based medicine, combined with individualised care tailored to each patient’s history, lifestyle, and clinical needs.

CameraBook a video appointment
5.017 reviews
Doctor

Yevgen Yakovenko

General surgery11 years of experience

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise: • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan. • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions. • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies. • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries. • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required. • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up. • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data. • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications: • 12+ years of clinical experience in university hospitals in Germany and Spain • International education: Ukraine – Germany – Spain • Member of the German Society of Surgeons (BDC) • Certified in radiological diagnostics and robotic surgery • Active participant in international medical conferences and research

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

CameraBook a video appointment
See all doctors

Stay informed and save on care

Get health tips, platform updates, and exclusive promos for subscribers.

Follow us on social media
FacebookInstagramTikTok
ServicesDoctorsHelp
Search